4 ms·
Study shows promise of new anti-KRAS drug for pancreatic cancer
- docmechanic 4y ago"A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers showed."